It is the cache of ${baseHref}. It is a snapshot of the page. The current page could have changed in the meantime.
Tip: To quickly find your search term on this page, press Ctrl+F or ⌘-F (Mac) and use the find bar.

Jornal Português de Gastrenterologia - Rastreio endoscópico do cancro colorrectal. Experiência de dois anos

SciELO - Scientific Electronic Library Online

 
vol.15 número4Prevenir o Cancro do Cólon e RectoRevisão das manifestações da hemocromatose A propósito de um caso clínico com 25 anos de evolução índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possui artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Bookmark

Jornal Português de Gastrenterologia

versão impressa ISSN 0872-8178

J Port Gastrenterol. v.15 n.4 Lisboa out. 2008

 

Rastreio endoscópico do cancro colorrectal. Experiência de dois anos

J. Cotter (1),(2), S. Lima (1),(2), S. Barroso (1),(2), C. Marinho (1), P. Moutinho (1), A. Rodrigues (1), L. Alberto (1), M. J. Moreira (1),(2), L. Lobo (1)

 

 

Resumo

Os métodos endoscópicos são considerados a forma mais válida de rastreio do cancro colorrectal e, como tal, métodos que devem ser utilizados caso haja disponibilidade de recursos. Apresenta-se uma análise retrospectiva da actividade de uma Unidade de Rastreio do Cancro do Cólon referente a um período de 24 meses, respeitante ao rastreio efectuado por colonoscopia (76,1%) e sigmoidoscopia flexível (23,9%) em 2700 indivíduos. Foi diagnosticado cancro colorrectal em 1% dos casos e pólipos adenomatosos em 38%, sendo 16,1% destes de risco (dimensões > 1 cm). Cerca de 89% das neoplasias malignas e 71 % dos pólipos localizavam-se no recto e sigmoide, consequentemente acessíveis à sigmoidoscopia flexível. Conclui-se que em face dos resultados encontrados, o rastreio endoscópico do cancro colorrectal deve ser implementado devido à sua eficácia diagnóstica e possibilidades terapêuticas (nomeadamente polipectomia), de preferência por colonoscopia e quando este método não estiver disponível, por sigmoidoscopia flexível.

 

 

Summary

Endoscopic methods are a precious and valid tool for colorectal cancer screening; therefore they should be embraced if resources are available. The authors present a retrospective analysis of a Colorectal Cancer  Screening Unit during a 24 month period, using colonoscopy (76,1%)and flexible sigmoidoscopy (23,9%) envolving 2700 patients. Colorectal cancer was diagnosed in 1% of the patients and polyps in 38%, 16,1% of these had increased risk (size >1cm). Near eighty nine per cent of malignant neoplasic lesions and 71% of the polyps were located in the rectum and sigmoid cólon, therefore detectable by flexible sigmoidoscopy. These results support the implementation of endoscopic screening of colorectal cancer because of its diagnostic effectiveness and therapeutic possibilities (namely polipectomy). When resources are available, colorectal cancer screening should be preferably performed by colonoscopy and if not, by flexible sigmoidoscopy.

 

 

Texto Completo disponível apenas em PDF

Full text only available in PDF format

 

 

Bibliografia

 

1 - Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJ. Global and regional estimates of cancer mortality and incidence by site: II. Results of the global burden of disease 2000. BMC Cancer 2003; 2: 37-63        [ Links ]

2 - Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, editors. Cancer incidence in five continents, vol. 8. Lyons: International Agency for Research on Cancer, 2002 (IARC Scientific Publications, nº 155) (PMID: 128122229)

3 - World Gastroenterological Organisation. Colorectal cancer screening, 2007

4 - Winawer SJ, Zauber AG, Fletcher RH, Zauber AG, Stillman JS, O’Brien MJ et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 2006; 130:1872-85

5 - Levin B, Barthel JS, Burt RW, David DS, Ford JM, Giardiello FM et al. Colorectal cancer screening clinical practice guidelines. J Natl Comp Canc Netw 2006; 4:384-420

6 - Levine JS, Ahmen DJ. Adenomatous polyps of the cólon. N Engl J Med 2006; 355:2551-7

7 - Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk; a summary of the evidence for the US Preventive Services Task Force Arm. Intern Med 2002; 137:132-41

8 - Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLOC) Cancer screening Trial. Control Clin Trials 2000; 21:273S-309S

9 - Cappell MS. Pathophysiology, clinical presentation, and management of cólon cancer. Gastr Clin of North Am 2008; 37:1-24

10 - Muto T, Bussy HJR, Morson BC. The evolution of cancer of the cólon e rectum. Cancer 1975; 36:2: 51-70

11 - Bond JH. Clinical evidence for the adenoma-carcinoma sequence, and the management of patients wih colorectal adenomas. Semin Gastrointest Dis 2000; 11: 176-84

12 - Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME, Colorectal Cancer Study Group. Fecal DNA versus fecal occult blood for colorectal cancer screening in na average-risk polulation. N Engl J Med 2004; 351:2704-14

13 - Cappel MS, Friedel D. The role of sigmoidoscopy and colonoscopy in the diagnosis and management of lower gastrointestinal disorders: endoscopic findings, therapy, and complications. Med Clin North Am 2002; 86:1253-88

14 - Mandel JS, Church TR, Bond JH, Ederer MS, Mongin SJ, Snover DC et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343:1603-7

15 - Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer in clinical practice: a prospective cohort study in Japan. Cancer Detect Prev 2007; 31:3-11

16 - Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J et al. A comparison cancer screening and surveillance: clinical guidelines and rationale – update based on new evidence. Gastroenterology 2003; 124:544-60

17 - This-Eveusen E, Hoff GS, Sanar J, Langmark F, Majak BM, Vatar MH. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol 1999; 34: 414-20

18 - Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M for the Italian Multicentre Study Group. Efficacy in standard clinical practice of colonoscopic polipectomy in reducing colorectal cancer incidence. Gut 2001; 48: 812-5

19 - Sommenberg A, Delco F, Inadomi JM. Cost-efectiveness of colonoscopy in screening for colorectal cancer. Am Intern Med 2000; 133: 573-84

20 - Lieberman DA, Weiss DG, Bond JH, Ahmen DJ, Garewall H, Chejfee C. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 2000; 343: 162-168

21 - Pinto A, Chaves P, Claro I, Lage P, Suspiro A, Chagas C et al. Rastreio do carcinoma do cólon e recto. Importância da sigmoidoscopia flexível. GE- Jornal Port Gastr 1997; 2 77-83

22 - Muller AD, Sommenberg A. Prevention of colorectal cancer by flexible sigmoidoscopy and polipectomy. A case-control study of 32702 veterans. Ann Intern Med 1995; 123: 904-10

 

 

(1) Unidade de Rastreio do Cancro do Cólon (Santa Casa da Misericórdia de Guimarães)

(2) Hospital da Senhora da Oliveira – Guimarães (Serviço de Gastrenterologia)

Correspondência:

José Cotter

Hospital da Senhora da Oliveira – Guimarães

Serviço de Gastrenterologia

Rua dos Cutileiros – Creixomil

4800- 055 Guimarães

 

Recebido para publicação: 18/05/2008

Aceite para publicação: 14/08/2008